CORTELLARO, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 5.379
NA - Nord America 4.442
AS - Asia 3.846
Continente sconosciuto - Info sul continente non disponibili 723
SA - Sud America 400
AF - Africa 109
OC - Oceania 8
Totale 14.907
Nazione #
US - Stati Uniti d'America 4.272
GB - Regno Unito 1.800
CN - Cina 1.239
SG - Singapore 1.146
IT - Italia 935
SE - Svezia 627
DE - Germania 509
RU - Federazione Russa 414
HK - Hong Kong 269
BR - Brasile 267
UA - Ucraina 263
VN - Vietnam 248
FR - Francia 238
IN - India 235
BD - Bangladesh 203
NL - Olanda 168
KR - Corea 141
TR - Turchia 134
CA - Canada 128
IE - Irlanda 127
EU - Europa 117
FI - Finlandia 102
CO - Colombia 62
PL - Polonia 53
JP - Giappone 44
CI - Costa d'Avorio 43
ID - Indonesia 40
BE - Belgio 23
AR - Argentina 21
ES - Italia 20
IQ - Iraq 20
ZA - Sudafrica 20
EC - Ecuador 18
MX - Messico 18
PK - Pakistan 18
DK - Danimarca 16
GR - Grecia 14
SA - Arabia Saudita 14
VE - Venezuela 14
UZ - Uzbekistan 13
MY - Malesia 12
AT - Austria 11
IL - Israele 11
PT - Portogallo 10
AE - Emirati Arabi Uniti 7
AL - Albania 7
AZ - Azerbaigian 7
CL - Cile 7
ET - Etiopia 7
MA - Marocco 7
RO - Romania 7
AU - Australia 6
KG - Kirghizistan 6
LU - Lussemburgo 6
SI - Slovenia 6
BG - Bulgaria 5
CH - Svizzera 5
IR - Iran 5
JM - Giamaica 5
KE - Kenya 5
KZ - Kazakistan 5
DZ - Algeria 4
EG - Egitto 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
UY - Uruguay 4
CR - Costa Rica 3
JO - Giordania 3
LT - Lituania 3
PA - Panama 3
TN - Tunisia 3
ZM - Zambia 3
AM - Armenia 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
ML - Mali 2
MU - Mauritius 2
MW - Malawi 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
TH - Thailandia 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
Totale 14.285
Città #
Southend 1.631
Singapore 592
Ashburn 429
Chandler 378
Beijing 309
San Jose 296
Hong Kong 244
Seattle 218
Jacksonville 215
Milan 199
Santa Clara 187
Princeton 159
Wilmington 140
Dublin 124
Mountain View 112
Council Bluffs 109
Los Angeles 100
Ann Arbor 98
Nanjing 96
Redmond 95
Bengaluru 93
Boardman 93
Woodbridge 89
Fairfield 85
New York 84
Frankfurt am Main 82
Dallas 81
Ho Chi Minh City 75
Dearborn 74
Lauterbourg 66
Sakarya 66
Toronto 64
Andover 58
Des Moines 57
Serra 57
Margão 56
Bogotá 52
Buffalo 51
Hanoi 51
Guangzhou 48
Somerville 48
Munich 46
Houston 44
Abidjan 43
Shanghai 43
Warsaw 43
Moscow 42
Nanchang 42
Rome 40
Hefei 38
Cambridge 37
Tokyo 37
Turin 34
Shenyang 32
Hangzhou 30
Jinan 30
Helsinki 28
Grafing 27
Columbus 26
Brussels 22
Tianjin 22
Phoenix 21
Berlin 20
Jakarta 20
Ottawa 19
Hanover 18
Medford 17
Dong Ket 16
Auburn Hills 15
Cangzhou 15
Changsha 15
Athens 14
Chicago 14
Da Nang 14
Hebei 14
Johannesburg 14
Shenzhen 14
São Paulo 14
The Dalles 14
Verona 14
Bitonto 13
Jiaxing 13
Redwood City 13
Wuhan 13
Atlanta 12
Eitensheim 12
Kunming 12
Kwai Chung 12
Naples 12
Bari 11
Roubaix 11
Roxbury 11
Florence 10
Fuzhou 10
Haiphong 10
Quanzhou 10
Taizhou 10
Zhengzhou 10
Belo Horizonte 9
Bologna 9
Totale 8.392
Nome #
Un caso di dolore osteo-muscolare non responsivo ai FANS 411
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 381
Calo ponderale e leucocitosi: quale la causa? 340
Are pleiotropic effects of statins real? 301
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients : the baseline findings of the MIAMI study 297
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction) : results of a prospective, multicenter study 283
Esordio tipico di emorragia cerebrale atipica 269
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study 254
Anemia emolitica: malattia o epifenomeno? 253
The MIAMI study (Markers of Inflammation and Atorvastatin effect in previous Myocardial Infarction): results of a prospective, open-label, multicenter study 250
Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease 249
The PLAT Study : a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients 245
Relationship between haemostatic variables and the progression of carotid atherosclerosis 245
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction): Results of a prospective, open-label, multicenter Study. 244
Inflammatory Markers and Carotid Intima Media Thickness (C-IMT) in Stable IHD Patients 242
Danno d’organo subclinico in una popolazione sovrappeso/obesa a rischio cardiovascolare intermedio 241
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group 241
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group 239
Progetto innovativo per migliorare la qualità della prevenzione cardio-cerebrovascolare attraverso un modello di integrazione Ospedale-Territorio e la valutazione di parametri non compresi nella definizione del rischio intermedio – Progetto CAPRESS 237
Regression of severe atherosclerotic lesions after vitamin replacement in hyperhomocysteinemia with multiple heterozygous mutations 234
Hemostatic variables and progression of common carotid intima-media thickness in patients with peripheral arterial disease 234
Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment 233
Psicosi acuta ed epilessia: quale alterazione metabolica 231
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group 226
Target organ damage in a population at intermediate cardiovascular risk, with adjunctive major risk factors : CArdiovascular PREvention Sacco Study (CAPRESS) 221
Un caso da manuale 220
Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study 220
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 215
Effetti di Atorvastatina su markers solubili aterosclerosi carotidea : Risultati dello Studio MIAMI 213
The PLAT Study : hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group Progetto Lombardo Atero-Trombosi (PLAT) Study Group 213
Subclinical disease (SD) in overweight and obese individuals at intermediate cardiovascular (CV) risk 209
Target organ damage in an asymptomatic population at intermediate cardiovascular risk and adjunctive major risk factors : the cardiovascular prevention Sacco study (CAPRESS) 203
E-Selettina e l’inibitore del fattore tissutale (TFPI) correlano con l’inspessimento medio-intimale carotideo (C-IMT) in pazienti con malattia ischemica coronarica in fase di stabilità clinica: risultati basali dello Studio MIAMI 197
Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina : results from the Lescol Intervention Prevention Study (LIPS) 194
A case of multiorgan atherosclerotic disease in patient affected by hyperhomocistinemia with multiple heterozigous muattions 192
Arteriosclerosi e suscettibilità d'organo 189
Cirrosi biliare primitiva ama negativa esordita con grave osteoporosi 186
E-selectin and TFPI are associated with carotid intima-media thickness in stable coronary patients : the baseline findings of the MIAMI Study 184
Come migliorare la stratificazione del rischio intermedio 183
Soluble E-Selectin and tissue factor pathway inhibitor, but not C-reactive protein, correlate with carotid intima-media thickness (C-IMT) in stable coronary patients: the baseline data of the MIAMI Study 182
Regression of severe atherosclerotic lesions after vitamin replacement in hyperhomocysteinemia with multiple heterozygous mutations 182
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 179
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy) 177
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia 177
Relazione tra variabili emostatiche e modificazioni dell'ispessimento intimale della carotide in pazienti con malattia ischemica periferica 170
Relation between hemostatic variables and changes of carotid intima-media thickness in PAD patients 169
Inibitori della COX-2: una promessa non mantenuta? Il parere dell'internista 167
Markers of hemostatic system activation during thromboprophylaxis with recombinant hirudin in total hip replacement 167
Progetti regionali innovativi area cardiocerebrovascolare 165
Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukemia: a randomised, heparin-controlled pilot study 164
Effect of atorvastatin on coagulation and inflammatory variables in patients with bilateral carotid stenosis. 161
Valutazione della lesione d'organo subclinica nei soggetti a rischio cardiovascolare intermedio: un progetto di intehgrazione ospedale-territorio 160
Polineuropatia sensitivo-motoria acuta e febbre : un caso di panarterite 160
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease : the DAVID study 160
null 159
Inflammatory Markers and C-IMT in Patients with Previous Myocardial Infarction. The Atorvastatin Effect . MIAMI Study 156
Idarubicin in the therapy of acute myeloid leukemia : final analysis in 57 previously untreated patients 148
Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia 147
Does the metabolic syndrome predict subclinical atherosclerotic damage in an asymptomatic population at intermediate cardiovascular risk? 142
Fibrinolytic variables in prediction of atherothrombotic sequelae in patients with preexisting vascular ischaemic disease : the plat study 141
Dai grandi trials alla pratica clinica: l’esempio delle statine 140
Markers infiammatori solubili ed evoluzione della placca aterosclerotica : effetto del trattamento con statina a dosi moderate in pazienti con cardiopatia ischemica stabile : studio MIAMI 140
The antiatherothrombotic effects of Atorvastatin : the ATROCAP Study results 140
Un insolito caso di malassorbimento 139
The regression between multiple inflammatory markers and C-IMT in normocholesterolemic stable IHD. The effect of moderate dose of atorvastatina (MIAMI study) 139
Dermatan sulphate in acute leukaemia 138
Fibrinolytic variables in atherosclerotic patients-comparison between patients with and without peripheral arterial-disease (PAD) 134
Esiste realmente l'effetto antinfiammatorio delle statine? 132
Antiatherosclerotic and antiatherothrombotic effects of statins 130
Flogosi granulomatosa polmonare in B-LLC trattata con fludarabina 130
Switching statins : an appropriate guideline for clinical practice? 129
Placca o individuo a rischio? 129
Biomarkers ed evoluzione della placca 120
Progetto pilota di collaborazione tra medici di medicina generale e ospedale per migliorare la valutazione del rischio cardiovascolare in soggetti a rischio intermedio. 118
Inflammatory markers and C-IMT in patients with previous myocardial infarction. The atorvastatin effect. MIAMI Study 100
FVIII-C-VWF-AG, fibrinogen, PAI-1 and leukocytes are associated with ischemic events in vascular-disease patients : the plat study 93
null 4
Totale 14.907
Categoria #
all - tutte 36.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022714 0 28 27 41 33 58 83 49 90 51 72 182
2022/20231.238 150 152 112 144 154 226 26 71 139 4 47 13
2023/2024631 20 53 45 35 142 70 11 64 14 19 80 78
2024/20251.865 76 147 19 186 165 90 71 154 117 154 106 580
2025/20263.720 389 201 284 331 314 265 462 158 418 345 270 283
2026/2027219 202 17 0 0 0 0 0 0 0 0 0 0
Totale 14.907